The incidence of 20q deletion is about 4% in MDS patients.
20q chromosome deletion probe labels the D20S108 region with an orange-red dye and the 20q13 region with a green dye.
The prognosis of MDS patients with 20q deficiency is good. Immunosuppressive therapy is effective for MDS patients with 20q deficiency alone.
Product size: 100μL FISH probe ( ⬤ | ⬤ ) + Pretreatment reagent (10 tests) + Antifade staining solution DAPI (10 tests).